Heptral 500mg 20 tablets

Heptral Composition:
active ingredient: ademetionine;
1 tablet contains 949 mg of ademetionine 1,4-butane disulfonate, which corresponds to 500 mg of ademetionine cation;
excipients: colloidal silicon dioxide, microcrystalline cellulose, sodium starch (type A), magnesium stearate, methacrylate copolymer (type A), polyethylene glycol 6000, polysorbates, simethicone emulsion, sodium hydroxide, talc.

Pharmacotherapeutic group:
Means that affect the digestive system and metabolic processes. Amino acids and their derivatives. ATX code A16A A02.

Indications:

• Intrahepatic cholestasis in adults, including patients with chronic hepatitis of various etiologies and liver cirrhosis
• Intrahepatic cholestasis in pregnant women.

Dosage and administration:
Treatment can begin with parenteral administration of the drug (use the drug Heptral in the form of a lyophilized powder for the preparation of a solution for injection complete with a solvent), followed by the use of the drug in the form of tablets or immediately after the use of tablets. The daily dose of tablets can be divided into 2-3 doses.

Tablets should be swallowed whole, without chewing. Tablets of the drug Heptral are coated with a special shell, which dissolves only in the intestine, due to which ademetionine is released in the duodenum. For better absorption of the active substance and for the full therapeutic effect, the tablets should be taken between meals.

The tablet of the drug Heptral should be removed from the blister immediately before taking. If the tablets have a color other than white to yellowish (due to the violation of the integrity of the aluminum wrapper), it is recommended to refrain from using them.

Initial Therapy
Orally (orally) the recommended dose is 10-25 mg/kg of body weight per day. The initial dose is 800 mg / day, the total daily dose should not exceed 1600 mg.

Supportive Therapy
Apply orally (by mouth) 800-1600 mg / day. The individual initial and maintenance dose should be determined by the physician depending on the body weight and severity of the disease, as well as taking into account the available dosages of the drug in circulation.

The duration of therapy depends on the severity of the course of the disease and is determined by the doctor individually.

Produced in Italy